Patient Access

Qualifying conditions, patient registries, prescription frameworks, and ID programs.

Patient-access frameworks define who can receive medical cannabis and how: qualifying-condition lists or physician-discretion models, specialist versus GP prescribing, patient registries, and reimbursement rules. These design choices determine the real size of a market more directly than any other regulatory factor.

Two structural models dominate: enumerated-condition systems (common in US states and newer programs) and discretion systems where any indication may be prescribed at physician judgment (Germany, Australia SAS-B). Reimbursement is the multiplier — Germany's statutory-insurance coverage decision turned it into the largest medical cannabis market in the EU.

Key considerations

• Qualifying-condition lists vs physician-discretion prescribing
• Specialist-only vs GP prescribing changes patient funnel size
• Registries and patient ID programs track eligibility and possession limits
• Reimbursement and prior authorization drive real-world access volume
• Possession limits and product-form restrictions vary per program